EMILY EUSTIS: Open Payments
NPI 1922434547 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$143 in 8 payments from 6 companies in 2025. Trend: 2023 $307 · 2024 $169 · 2025 $143
Food & beverage: $143
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $60 |
| MILLICENT US INC | 1 | $21 |
| Astellas Pharma Global Development | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $12 |
Products named: Veozah, FEMRING, Lynkuet, Wegovy, Phexxi.
Industry payments across NC — which companies pay providers there.
